Renovaro Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
RENB Company Description
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
RENB Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RENB Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of RENB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RENB's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of RENB in WallStreetBets Daily Discussion
RENB News
Recent insights relating to RENB
CNBC Recommendations
Recent picks made for RENB stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RENB
Corporate Flights
Flights by private jets registered to RENB
Our Analysis